loadpatents
name:-0.016457080841064
name:-0.0079090595245361
name:-0.001561164855957
NEWMAN; Mary Patent Filings

NEWMAN; Mary

Patent Applications and Registrations

Patent applications and USPTO patent grants for NEWMAN; Mary.The latest application filed is for "lfa-1 inhibitor formulations".

Company Profile
1.6.13
  • NEWMAN; Mary - Brisbane CA
  • Newman; Mary - Valrico FL
  • Newman; Mary - Durham NC
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Lfa-1 Inhibitor Formulations
App 20220000859 - NEWMAN; Mary ;   et al.
2022-01-06
LFA-1 inhibitor formulations
Grant 11,058,677 - Newman , et al. July 13, 2
2021-07-13
Exo-S-mecamylamine formulation and use in treatment
Grant 10,188,613 - Shytle , et al. Ja
2019-01-29
Exo-s-mecamylamine Formulation And Use In Treatment
App 20180250244 - SHYTLE; DOUGLAS ;   et al.
2018-09-06
Exo-s-mecamylamine Formulation And Use In Treatment
App 20170181983 - SHYTLE; DOUGLAS ;   et al.
2017-06-29
Exo-S-mecamylamine formulation and use in treatment
Grant 9,593,070 - Shytle , et al. March 14, 2
2017-03-14
Continuous Flow Carboxylation Reaction
App 20160090361 - Tweedie; Scott ;   et al.
2016-03-31
Lfa-1 Inhibitor Formulations
App 20150320737 - NEWMAN; Mary ;   et al.
2015-11-12
Exo-s-mecamylamine Formulation And Use In Treatment
App 20140194525 - Shytle; Douglas ;   et al.
2014-07-10
Exo-S-mecamylamine formulation and use in treatment
Grant 8,026,283 - Shytle , et al. September 27, 2
2011-09-27
Exo-s-mecamylamine Formulation And Use In Treatment
App 20110028565 - Shytle; Douglas ;   et al.
2011-02-03
Exo-s-mecamylamine Formulation And Use In Treatment
App 20100286282 - Shytle; Douglas ;   et al.
2010-11-11
Exo-S-Mecamylamine Formulation and Use in Treatment
App 20060276551 - Shytle; Douglas ;   et al.
2006-12-07
Exo-S-mecamylamine formulation and use in treatment
Grant 7,101,916 - Shytle , et al. September 5, 2
2006-09-05
Exo-S-mecamylamine formulation and use in treatment
Grant 6,734,215 - Shytle , et al. May 11, 2
2004-05-11
Exo-S-mecamylamine formulation and use in treatment
App 20040044083 - Shytle, Douglas ;   et al.
2004-03-04
Exo-S-mecamylamine formulation and use in treatment
App 20020016371 - Shytle, Douglas ;   et al.
2002-02-07
Exo-R-mecamylamine formulation and use in treatment
App 20020016370 - Shytle, Douglas ;   et al.
2002-02-07
Company Registrations
SEC0001679132NEWMAN MARY

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed